Current role
Sharon Benzeno
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sharon Benzeno
The proxy statement of Adaptive Biotechnologies Corp reports total compensation of $1,796,594 for Sharon Benzeno in fiscal 2024, including a base salary of $475,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Adaptive Biotechnologies Corp (ADPT)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Adaptive Biotechnologies Corp
Other people whose current roles at this company are on record from its filings.
- Chad Robins CEO, Board Member
- Kyle Piskel CFO, Chief Accounting Officer
- Julie Rubinstein COO
- Stacy Taylor General Counsel
- Katey Einterz Owen Board Member
- Katey Owen Board Member
- Robert Hershberg Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, IM | $475,000 | $1,796,594 |
| 2023 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, IM | $475,000 | $2,880,721 |
| 2022 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Officer, IM | $456,250 | $3,237,784 |
Recent activity
No call appearances or filed executive changes recorded yet.